HEARO A CORDIO APP
Live / Registered — Registered (as of 25 Feb 2025)
What this means for you
Registered since 25 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88836791
- Registration number
- 7706512
- Mark type
- Stylized text
- Filed
- 17 Mar 2020
- Published for opposition
- 25 Aug 2020
- Registered
- 25 Feb 2025
- Attorney of record
- M. Scott Alprin
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable computer software which enables the analysis of human voice, vocal, speech and breathing for the purpose of medical diagnosis and monitoring; Computer hardware for use with recording and providing programmed alerts for transmission of human voice, vocal, speech and breathing; none of the foregoing goods for use in automated monitoring of patients with intellectual and developmental disabilities by families and provider agencies
- Class 010 — Medical apparatus: Medical diagnostic voice sensors for the purpose of medical diagnosis and monitoring of human voice, vocal, speech and breathing
Owner
- Cordio Medical Ltd., Or Yehuda, IL
- Cordio Medical Ltd., Or Yehuda, IL
- Cordio Medical Ltd., Or Yehuda, IL
Prosecution history
- 05 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Nov 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 05 Nov 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Nov 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 Feb 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Feb 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Feb 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 15 Oct 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 15 Oct 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 12 Aug 2024 — NOTIFICATION OF SU - SUBSEQUENT FINAL E-MAILED
- 12 Aug 2024 — SU - SUBSEQUENT FINAL MAILED